Docoh
Loading...

VIVO Meridian Bioscience

616 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
VIVO Meridian Bioscience Inc.
2 Dec 21
Meridian Bioscience Announces Retirement of CFO Bryan Baldasare
8:11am
10-K
2021 FY
VIVO Meridian Bioscience Inc.
23 Nov 21
Annual report
8:46am
4
Lourdes Weltzien
16 Nov 21
MERIDIAN BIOSCIENCE / LOURDES WELTZIEN ownership change
4:01pm
4
Tony Serafini-Lamanna
16 Nov 21
MERIDIAN BIOSCIENCE / Tony Serafini-Lamanna ownership change
3:59pm
4
Baldasare Bryan T
16 Nov 21
MERIDIAN BIOSCIENCE / Bryan T Baldasare ownership change
3:58pm
4
Kenny John P.
16 Nov 21
MERIDIAN BIOSCIENCE / John P. Kenny ownership change
3:56pm
8-K
VIVO Meridian Bioscience Inc.
12 Nov 21
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-year Fiscal 2021 Operating Results and Provides Fiscal 2022 Guidance
7:38am
8-K
VIVO Meridian Bioscience Inc.
10 Nov 21
Meridian Bioscience Receives FDA Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
9:03am
4
Lourdes Weltzien
8 Nov 21
MERIDIAN BIOSCIENCE / LOURDES WELTZIEN ownership change
4:12pm
4
Tony Serafini-Lamanna
8 Nov 21
MERIDIAN BIOSCIENCE / Tony Serafini-Lamanna ownership change
4:10pm
4
Baldasare Bryan T
8 Nov 21
MERIDIAN BIOSCIENCE / Bryan T Baldasare ownership change
4:09pm
4
Kenny John P.
8 Nov 21
MERIDIAN BIOSCIENCE / John P. Kenny ownership change
4:06pm
8-K
VIVO Meridian Bioscience Inc.
29 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:02pm
8-K
VIVO Meridian Bioscience Inc.
1 Sep 21
Regulation FD Disclosure
4:41pm
10-Q
2021 Q3
VIVO Meridian Bioscience Inc.
6 Aug 21
Quarterly report
8:32am
8-K
VIVO Meridian Bioscience Inc.
6 Aug 21
Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
8:13am
8-K
VIVO Meridian Bioscience Inc.
2 Aug 21
Meridian Closes Acquisition of BreathTek® Business
9:53am
8-K
VIVO Meridian Bioscience Inc.
23 Jul 21
Other Events
10:11am
8-K
VIVO Meridian Bioscience Inc.
13 Jul 21
Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter
10:16am
8-K
VIVO Meridian Bioscience Inc.
28 Jun 21
Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
11:37am